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Abstract 
Practical solutions for multiple antibiotic determination in food is required by the food 
industry and regulators for cost effective screening purposes. This study describes the 
feasibility in development and preliminary performance of a novel multispot nanoarray for 
antibiotic screening in honey. Using a multiplex approach the metabolites of the four main 
nitrofuran antibiotics including morpholinomethyl-2-oxazolidone (AMOZ), 3-amino-2-
oxazolidinone (AOZ), semicarbazide (SEM), 1-aminohydantoin (AHD) and chloramphenicol 
(CAP) were simultaneously detected. Antibodies specific to the five antibiotics were nano-
spotted onto microtitre plate wells and a direct competitive assay format was employed. The 
assay characteristics and performance were evaluated for feasibility as a screening tool for 
antibiotic determination in honey to replace traditional ELISAs. Optimisation of the spotting 
and assay parameters were undertaken with both individual and multiplex calibration curves 
generated in PBS buffer and a honey matrix. The limits of detection as determined by the 
20% inhibitory concentrations (IC20) were determined as 0.19, 0.83, 0.09, 15.2 and 35.9 
ng/mL in PBS buffer,  0.34, 0.87, 0.17, 42.1 and 90.7 ng/mL in honey (fortified at the start of 
the extraction) and 0.23, 0.98, 0.24, 24.8 and 58.9 ng/mL in honey (fortified at the end of the 
extraction) for AMOZ, AOZ, CAP, SEM and AHD respectively. This work has demonstrated 
the potential of multiplex analysis for antibiotics with results available for 40 samples within 
a 90 min period for antibiotics sharing a common sample preparation. Although both the 
SEM and AHD assay do not show the required sensitivity with the antibodies available for 
use to meet regulatory limits, with further improvements in these particular antibodies this 
multiplex format has the potential to show a reduction in cost with reduced labour time in 
combination with the high throughput screening of samples. This is the first 96 well spotted 
microtitre plate nanoarray for the semi-quantitative and simultaneous analysis of antibiotics.  
 
Keywords: nanoarray, screening method, immunoassay, antibiotic, nitrofurans, AMOZ, 
AOZ, SEM, AHD, chloramphenicol, honey.  
 
Introduction 
Antibiotics are a vital component for the treatment and elimination of disease in human, 
plants and animals. There are many concerns regarding the human consumption of food 
products contaminated with drug residues such as antibiotics. Antibiotic residues from 
agricultural use must be carefully monitored as they can adversely impact public health due 
to allergenic and carcinogenic factors and may also contribute to bacterial resistance. 
Nitrofurans belong to a class of synthetic broad spectrum antibiotics which all contain the 
characteristic five-membered nitrofuran ring. They were commonly used as feed additives for 
growth promotion and used mainly for livestock, aquaculture and apiculture for the 
prophylactic and therapeutic treatment of bacterial infections. Parent nitrofuran compounds 
are quickly metabolised after ingestion and have very short in vivo half-lives. Monitoring of 
nitrofurans is therefore based on the monitoring of the tissue-bound metabolites of nitrofurans 
as they remain in the body for many weeks after treatment (McCracken and Kennedy, 1997; 
Cooper et al., 2005). The four main nitrofuran antibiotics are furaltadone, furazolidone, 
nitrofurazone and nitrofurantoin with the resulting tissue bound metabolite residues AMOZ, 
AOZ, SEM and AHD produced respectively. There is however increasing concern in the use 
of SEM as a marker for nitrofurazone due to its reported natural occurrence in seafood, eggs, 
whey and heather honey (Crews, 2012) but recommendations in the measurement of total and 
comparison of between free and protein bound SEM may offer a solution until an alternative 
marker is identified (Points et al., 2015). The nitrofuran metabolites have also been shown to 
be stable after cooking with 67-100 % of the residues remaining after conventional cooking 
techniques and additionally there was no significant change in residue concentration after 
storage at -20 °C (Cooper and Kennedy, 2007). In 1995, the use of nitrofurans for livestock 
production was completely prohibited in the European Union (EU) due to concerns about the 
carcinogenicity and their potential harmful effects on human health. Nitrofuran antibiotics 
have been included in Commission Regulation (EC) 1442/95 as compounds that are not 
permitted for use in the livestock industry. The EU has established a minimum required 
performance limit (MRPL) of 1 µg/kg for tissue of animal origin. There is however 
increasing concern in the use of SEM as a marker for nitrofurazone due to its natural 
occurrence in seafood, eggs, whey and heather honey (Crews et al., 2012). CAP is a broad 
spectrum antibiotic with excellent antibacterial and pharmacokinetic properties. This 
antibiotic is proven to be valuable for the treatment of bacterial infections in human and 
veterinary medicine as well as being administered to animals for disease prevention. It is 
often associated with serious side effects such as the development of aplastic anaemia and 
bone marrow suppression (Jimenez et al., 1990). In 1994, CAP was included in the Annex 
IV of the Council Regulation (EEC) No. 2377/90 and is therefore banned in the EU for the 
treatment of food producing animals. Consequently, CAP may not be present in animal 
products for human consumption and a MRPL of 0.3 μg/kg in meat, eggs, milk, urine, 
aquaculture products and honey has been set.  
As both the nitrofurans and CAP are prohibited substances, zero tolerance applies. Methods 
of detection therefore require very low detection limits and high sample throughput. The 
development of rapid, inexpensive, accurate, multi residue and easy to use screening methods 
are therefore of primary importance in the food industry. Sensitive methods for nitrofuran 
metabolites for both screening (ELISA) and confirmatory methods (LC-MS/MS) were first 
developed by the EU FoodBRAND project (Cooper et al., 2004a; 2004b; Cooper et al., 
2005). Analytical procedures for nitrofuran analysis in various matrices by screening and 
confirmation methods with respect to EU regulations are reviewed in Vass et al. (2008). 
Although analytical methods, HPLC-UV and LC-MS/MS, are available for both nitrofurans 
and CAP (Conneely et al., 2003; O’Keeffe et al., 2004; Cooper et al., 2005; Vivekanandan et 
al., 2005; Han et al., 2011; Douny et al., 2013), it is acknowledged that these methods are 
expensive, require skilled personnel and are time consuming. The need therefore for simple, 
rapid and efficient analytical methods for antibiotics that can be handled by relatively 
unskilled operators has been recognised. Additionally, affordable monitoring of antibiotics to 
ensure food safety requires high throughput and economical methods of detection. To date a 
range of methods for the determination of nitrofuran metabolites and CAP residues in 
foodstuff have been developed. Independent enzyme linked immunosorbent assays (ELISAs) 
are widely used for screening purposes for each nitrofuran metabolite (Cooper et al., 2004; 
Diblikova et al., 2005; Cooper et al., 2007; Cheng et al., 2009; Li et al., 2009) and CAP 
(Fodey et al., 2007; Liu et al., 2014; Guo et al., 2015) thereby requiring five ELISA assays to 
detect all targets. Commercial screening tests are available for honey from Abraxis, 
Europroxima, Randox Food Diagnostics, R-Biopharm, Romer Labs and Tecna for nitrofurans 
detection and from Europroxima, Randox Food Diagnostics, R-Biopharm, Tecna and Bioo 
Scientific for CAP detection. Biosensors have also been developed for honey for the 
independent detection of individual nitrofuran metabolites (Jin et al., 2011; Yang et al., 2011; 
Jin et al., 2014) and CAP (Ferguson et al., 2005; Yan et al., 2012; Kara et al., 2013; Gao et 
al., 2014). There is, however, an increasing necessity for the development and 
implementation of multiplexed tests that can detect a range of antibiotics simultaneously thus 
serving to reduce operator time and costs. Multiplex assays for nitrofurans include both 
antibody based screening methods (Thompson et al., 2011; O’Mahony et al., 2011; Liu et al., 
2015) and confirmatory physiochemical LC-MS/MS methods (Tribalat et al., 2006; Lopez et 
al., 2007) for the detection of all four nitrofurans simultaneously. LC-MS/MS multiple 
analyte  tests are also described for the simultaneous detection of the nitrofuran metabolites 
and CAP (An et al., 2015, El-Demerdash et al., 2015, Veach et al., 2015; Kaufmann et al., 
2015). The only commercial test available for multiple antibiotic detection is from Randox 
Food Diagnostics based on a customised biochip technology with chemiluminescent 
detection for the four main nitrofuran metabolites..  
In recent years innovative nano science and technology with state of the art sensing 
equipment have allowed the emergence of novel detection platforms. Nanoarrays have 
become unique and important tools for high-throughput analysis providing promising 
methods in which several targets are separately detected in spatially defined zones 
simultaneously. This enables miniaturization, higher sensitivity and simplified sample 
preparation in combining multiple extraction procedures into a single procedure. Nanoarrays 
may be employed in a number of applications such as medical diagnosis, genetic testing, 
environmental monitoring and food safety. There are very few studies that effectively employ 
this promising technology for the detection of antibiotics. An immunoassay using the 
microarray chip reader 3 platform has been described for the determination of antibiotic 
residues in milk (Kloth et al., 2009a; 2009b) and honey (Wutz et al. 2011). A novel 
multiplex nanoarray based on planar waveguide with fluorescence detection was developed 
for the detection of a number of antibiotics including CAP (McGrath et al., 2015) in milk. 
Nanoarray formats in 96 well microtitre plates provide very promising and powerful 
detection methods in which several targets can be detected simultaneously. The benefits of 
ELISA and nanoarrays can thus be combined to produce a multiplex test capable of 
conducting large surveys and high throughput but also the simultaneous semi-quantitative 
detection of many antibiotics by users already familiar with ELISA methods. 
Apiculture relies on antibiotics to prevent disease spreading through bee colonies, however, 
the overuse of these antibiotics can cause residues in honey products. Honey is one of the 
many foods that are monitored for antibiotic residues worldwide. Honey producers, 
importers, exporters and regulators, therefore, need simple, fast and effective ways to test 
honey for antibiotics. The development of sensitive, multi residue, rapid and high throughput 
screening methods are therefore important in the area of food safety and residue 
determination. The aim of this research was to demonstrate feasibility of a direct competitive 
multiplex nanoarray in a 96 well microtitre plate for the simultaneous detection of five key 
banned antibiotics (AMOZ, AOZ, SEM, AHD and CAP) in honey as a rapid and easy to use 
detection system. 
 
Materials and methods 
Instrumentation   
A sciFLEXARRAYER S5 (Scienion, Germany) was used for spotting microtitre plates and a 
sciReader CL colorimetric nanoarray reader (Scienion, Germany) was used for scanning and 
analysing spot intensities. 
 
Reagents 
Antibodies and enzyme labelled HRP conjugates for AMOZ, AOZ, SEM, AHD and CAP 
were provided by Tecna (Trieste, Italy). Nunc 96 well microtitre plates (442404 flat bottom; 
473768 breakable) were purchased from VWR (Leicestershire, UK). SciColor T2, enzyme 
substrate solution, was purchased from Scienion (Berlin, Germany). Methanol, hexane, 
dimethyl sulfoxide, ethyl acetate (all HPLC grade), 2-nitrobenzaldyde, dipotassium 
phosphate, bovine serum albumin, CAP, 2-NP-AMOZ, 2-NP-AOZ, 2-NP-SEM and 2-NP-
AHD were all purchased from Sigma-Aldrich (Dorset, UK). CAP, 2-NP-AMOZ, 2-NP-AOZ, 
2-NP-SEM and 2-NP-AHD were all prepared as 1mg/mL stock standards in methanol and 
stored at -20°C until required for use. 
 
Spotting nanoarrays 
Purified antibodies were diluted in filtered printing buffer (100 mM sodium phosphate, 50 
mM sodium chloride, 100 μg/mL BSA, 0.005 % Tween-20, pH 8.0) to the required 
concentration (depending on the antibody). A spotting volume of 1 nL for each antibody was 
spotted onto a 96 well microtitre plate using a sciFLEXARRAYER S5. For part one of the 
study (optimisation) a nine spot matrix format (3x3 array) was arrayed with a 1000 µm spot 
to spot pitch composing of nine replicates of each target in separate wells. For part two of the 
study (multiplex spotting analysis) a 25 spot matrix format (5x5 array) was arrayed with a 
500 µm spot to spot pitch composed of five replicates of each target (x 5 targets) in the same 
well. All spotting was carried out at room temperature and 65 % humidity. Microtitre plates 
were left at 65 % humidity for 1 hr on the nanospotter before being stored at 25 °C and 30 % 
humidity overnight in a humidity chamber (Deny, China). 
 
Assay protocol 
Enzyme labelled HRP conjugate (50 µl) diluted in bovine serum albumin (0.2 %) and 
sample/standard (50 µl) were applied to each well. The microtitre plate was incubated for 60 
min at room temperature. The microtitre plate was washed 4 times with ELISA wash solution 
(0.15 M NaCl, 0.0125 % Tween) and dried with lint-free paper. SciColor T2 (50 µl) was 
added to each well and incubated for 30 min at room temperature. Finally, the microtitre plate 
was washed 2 times with ELISA wash solution and dried with lint-free paper. The microtitre 
plate was scanned using the sciReader CL colorimetric nanoarray reader. 
 
Data processing 
Microtitre plates were scanned using the sciReader colorimetric nanoarray reader at an 
exposure of 100 ms. An image of each well of the microtitre plate was taken and saved as a 
TIFF file. One microtitre plates takes approximately 1 min to scan. The images are opened 
and processed using sciANA software from Scienion. The spotting matrix of each well is 
defined by the number of blocks (1x1) and number of spots (5x5) so that the software knows 
the spotting configuration. Next the image is evaluated and the software attempts to find the 
spotting configuration that has been specified. If the software successfully detects the spots it 
will draw grids around each spot automatically. If the intensity difference between the spots 
and the background is too low the software will not be able to find the spots and instead the 
grids must be manually aligned by the user. Once grids are aligned then the data can be 
exported into Excel. The Excel sheet will contain information on each spot of the well 
including X and Y coordinates, diameter, median intensity of spot and intensity of 
background. The median intensity (with background removed) measured in pixels was used 
for further data analysis. 
 
Optimisation of assay set-up 
Key materials and reagents were assessed to determine the optimum assay set-up. These 
included the microtitre plate supplier for spotting (Scienion (Clear Scienion Type 1 (CPH-
5511); Clear Scienion Type 2 (CPH-5521)), Nunc (White plates 463201; Flat bottom 442404; 
Breakable 473768) and Millipore (MSFBN6B50), and the TMB/E supplier for the assay 
(Millipore and Scienion).  
 
Optimisation of spotting volume 
Both 1 nL and 5 nL spotting volumes were initially assessed for AMOZ, AOZ and CAP 
assays to determine any effects on assay performance. By applying the optimised antibody 
dilutions of AMOZ (1/2000), AOZ (1/1000) and CAP (1/1000) and enzyme labelled HRP 
conjugates at AMOZ (1/4000), AOZ (1/100) and CAP (1/1000), eight-point calibration 
curves, from 0 to 50 ng/mL were prepared in PBS buffer for each antibiotic and assessed as 
an individual system (only one antibiotic spotted) with no interaction from any other 
antibiotic.  
 
Optimisation of antibodies and enzyme labelled HRP conjugates 
A chequerboard design was employed to optimise the assay parameters. Microtitre plates 
were spotted in an individual system using antibodies to determine optimum parameters for 
each antibiotic. Microtitre plates were spotted using purified antibodies at a spotting volume 
of 1 nL at dilutions 1/50 – 1/500 for AHD, 1/250 – 1/2000 for AOZ and CAP and 1/500 – 
1/4000 for AMOZ and SEM. Spotted antibodies were assessed as a chequerboard with 
individual enzyme labelled HRP conjugates at different dilutions (1/50 – 1/8000). A negative 
(0 ng/mL) and positive (10 ng/mL) standard were assessed for each parameter to determine 
optimum assay parameters for each antibiotic. The optimised antibody dilutions were for 
AMOZ (1/2000), AOZ (1/1000), SEM (1/4000), AHD (1/250) and CAP (1/1000) and the 
optimised enzyme labelled HRP were for AMOZ (1/4000), AOZ (1/100), SEM (1/1000), 
AHD (1/100) and CAP (1/1000). 
 
Individual and multiplex calibration curves 
Microtitre plates were spotted in a multiplex system (AMOZ, AOZ, SEM, AHD and CAP) 
and both individual and multiplex calibration curves were assessed. Spotting and assay 
parameters were determined during the optimisation stage. The microtitre plates were spotted 
using purified antibodies at a spotting volume of 1 nL using different antibody dilutions 
depending on the antibody. Antibody dilutions for each antibody were as follows; AMOZ 
(1/2000), AOZ (1/1000), SEM (1/4000), AHD (1/250) and CAP (1/1000). Enzyme labelled 
HRP conjugates were used at the following dilutions for each antibody; AMOZ (1/4000), 
AOZ (1/100), SEM (1/1000), AHD (1/100) and CAP (1/1000) during the assay. Eight-point 
individual calibration curves for AMOZ, AOZ, SEM, AHD or CAP were prepared in PBS 
buffer (10 mM, pH 7.4) at concentrations 0, 0.05, 0.1, 0.5, 2, 5, 10 and 50 ng/mL (AMOZ, 
AOZ and CAP) and at concentrations 0, 1, 5, 10, 25, 50, 100 and 200 ng/mL (SEM and 
AHD). Eight-point multiplex calibration curves for AMOZ, AOZ, SEM, AHD and CAP were 
also prepared in PBS buffer. Where necessary further standards were added as additional 
calibration points to improve the curve shape for the multiplex calibration curves especially 
for SEM and AHD. Calibration curves were assessed and examined (n=2 analysis, 5 spots per 
analysis) and sensitivity as either the midpoint (IC50) for full curves or the 50% inhibition 
concentration from the zero response determined from a 4 parameter fit curve using 
BIAevaluation version 4.1 software (Biacore, GE Healthcare). 
 
Sample preparation 
Hexane (5 mL), 1 M HCl (0.5 mL) and distilled water (4 mL) were added to honey (1 g) and 
vortex mixed for 1 min. The sample was centrifuged at 3000 g for 10 min and frozen at -80 
°C for 2 hr in order to separate the phases. The upper phase was discarded and the lower 
aqueous phase was allowed to defrost. 2-Nitrobenzaldyde (10 mM) in dimethyl sulfoxide 
(200 µl) was added to the aqueous phase and the sample was incubated overnight at 37 °C. 
Dipotassium phosphate (0.1 M, 5 mL), NaOH (1 M, 0.4 mL) and ethyl acetate (5 mL) were 
added to the sample and vortexed for 1 min. The sample was centrifuged at 3000 g for 10 
min. The upper organic phase (2.5 mL) was transferred to a glass test tube and evaporated at 
50°C under a slow nitrogen stream. Finally, the residue was dissolved in 1 mL PBS (10 mM, 
pH 7.4).  
  
Matrix effects 
Microtitre plates were spotted for the multiplex format and assay parameters examined were 
as described previously. Blank material for honey was sourced by Queen’s University Belfast 
and was confirmed as blank for the analytes of interest. Calibration curves for AMOZ, AOZ, 
SEM, AHD and CAP covering the concentration range of 0 – 1000ng/mL were prepared in 
PBS buffer to achieve full calibration curves. Calibration curves were also prepared, 
equivalent in final concentration to the buffer curve for honey samples fortified at the start of 
extraction, and honey fortified at the end of extraction to determine matrix and recovery 
effects in the assay compared to the buffer curve.  
 
Results and Discussion 
Optimisation of assay set up 
Based on the selection of the microtitre plates assessed the Nunc flat-bottomed plates were 
chosen for the assay development based on the assay performance achieved and price 
compared to the competitor plates. Millipore TMB/E (E-S001) was deemed not suitable for 
this multiplex assay as this reagent re-mobilised the spots whereby the development reaction 
was observed throughout the well, merging spots instead of as individual spots. Alternatively, 
when using the SciColor T2 special enzyme substrate solution the reaction was observed on 
the individual immobilised spots within the well and the liquid could be removed prior to 
scanning.  
 
Optimisation of Spotting Volumes 
For the two spotting volumes of 1 nL and 5 nL individual eight-point calibration curves for 
each antibiotic (AMOZ, AOZ or CAP) were successful achieved (Figure 1). Similar curve 
shapes were observed between the two spotting volumes and there was minimal difference in 
sensitivity when applying the 1 nL or 5 nL spotting volume. Nonetheless, the smaller spots 
appeared sharper and were more clearly spatially defined.  Initially reagents were only 
available for the AMOZ, AOZ and CAP targets and therefore it was decided that the final 
nanoarray would be spotted at 1 nL; the smaller spotting volume enabled the addition of the 
further two targets AHD and SEM when these reagents became available.  
 
Optimisation of antibodies and enzyme labelled HRP conjugates 
For the optimisation of the pairing of antibody and enzyme labelled HRP conjugate for each 
target the dilutions were optimised to give a spot intensity for the 0 ng/mL at approximately 
20,000 pixels. At this level of signal there was significant improvements in the ease of grid 
alignments and the processing of data as the software was able to find the spotted nanoarrays 
and carry out grid alignments with the images automatically. Final assay parameters for the 
spotted antibodies were 1/2000, 1/1000, 1/4000, 1/250 and 1/1000 for AMOZ, AOZ, SEM, 
AHD and CAP respectively. Final assay parameters for the enzyme labelled HRP conjugates 
were 1/4000, 1/100, 1/1000, 1/100 and 1/1000 for AMOZ, AOZ, SEM, AHD and CAP 
respectively. These optimum parameters selected provided suitable results in terms of spot 
intensity and inhibition with the 10 ng/mL positive standard to develop further each assay. A 
relatively high concentration of 10 ng/mL was applied compared to the MRPLs for the 
positive control to observe a working dynamic range for AMOZ, AOZ and CAP between 
negative and positive controls and to observe inhibition for the AHD and SEM assays with 
detectable spot intensities. 
 
 
Individual and multiplex calibration curves 
Eight-point individual calibration curves determined for each antibiotic (AMOZ, AOZ, SEM, 
AHD or CAP) as individual curves in the multiplex format with all targets spotted in the 
assay were successfully achieved (Figure 2). Additionally, eight-point multiplex calibration 
curves for all five antibiotics (AMOZ, AOZ, SEM, AHD and CAP) analysed simultaneously 
in the multiplex assay were completed (Figure 3). Table 1 presents the limit of detection 
(LOD) of the assays, as the IC20, and midpoint, IC50, based on the midpoint of a full 
sigmoidal curve or the 50% inhibition concentration for partial curves for each target both in 
the individual assay and multiplex format. For AMOZ, AOZ and CAP the LODs achieved at 
0.09, 0.26 and 0.04 ng/mL as individual assays is suitable to meet the MRPL values of 1 
ng/mL and 0.3 ng/mL for the nitrofurans and CAP respectively. The LODs of these three 
individual assays are lower compared to when they are multiplexed at 0.19, 0.34 and 0.09 
ng/mL for AMOZ, AOZ and CAP respectively. For multiplexing the detection of these 
targets at the MRPLs is realistic. The IC50 was similar for CAP at approximately 0.8 ng/mL 
for both the individual and multiplex calibration curves. The IC50 increased from 1.2 ng/mL 
to 3.2 ng/mL for AMOZ and similarly for AOZ from 1.9 ng/mL to 3.1 ng/mL between the 
individual and multiplex calibration curves showing a decrease in sensitivity for AMOZ and 
AOZ. Multiplexing assays with different antibodies may lead to some degree of cross talk 
between targets which accounts for the increase in the IC20 and IC50 for the multiplex curves. 
The benefits of multiplexing can be a suitable compromise to a minimal loss of sensitivity in 
most applications. However, for SEM and AHD the antibodies utilised do not allow the 
assays to reach the desired LODs for these targets as individual assays with IC20 values 
established of 35.9 and 15.2 ng/mL respectively. Nonetheless, the proof of principle in 
multiplexing has still been established. With better-quality antibodies the LODs for these 
targets could be improved. The IC50 was greater than 200 ng/mL for both SEM and AHD for 
the individual calibration curves. For the multiplex calibration curves for the matrix study the 
calibration range was increased to 1000 ng/mL for both SEM and AHD to determine 
sensitivity (Figure 4). As expected the dynamic range for both SEM and AHD was improved 
and 50 % inhibition of 166.6 g/mL and 553.8 ng/ml respectively were obtained for the 
multiplex curves. Additionally, when assessed as individual calibration curves on multiplex 
spotted microtitre plates both SEM and AHD conjugates showed a degree of cross reactivity 
with other spotted antibodies. SEM was detected by the AMOZ, AOZ and AHD spotted 
antibodies and AHD was detected by the AOZ spotted antibody. Reduced sensitivities 
between the individual and multiplex calibration curves is possibly due to minor interference 
and non-specific binding of reagents between the assays. There was extremely good 
repeatability shown with the IC50 values shown for the first multiplex study in PBS buffer 
(Figure 3) compared to the PBS buffer data from the matrix study (Figure 4) as outlined in 
Table 1 though the LODs were more variable. 
  
Matrix effects 
For the examination of matrix and recovery effects for the multiplex assay, over the 
concentration range for the sample preparation method applied, calibration curves of 
equivalent concentration prepared in PBS buffer, honey fortified before extraction and honey 
fortified after extraction were generated (Figure 4). It should be noted that for nitrofuran 
analysis there is the added complexity in sample preparation in the derivatisation of the 
marker metabolites for their detection. Therefore the extraction and derivatisation remains an 
overnight process for all methods though the advantage of the nanoarray is that it offers the 
simultaneous analysis of the five targets from the one sample extract. Due to the sensitivity 
required to achieve the desired MRPL detection levels the matrix and recovery effects appear 
more pronounced at the LODs (IC20 values) compared to the midpoints (IC50 values) of the 
calibration curves (Table 1).  The comparison of matrix effects is determined by differences 
observed in the calibration curves prepared in PBS buffer and honey matrix fortified at the 
end of the extraction based on 100% recovery of the targets. Low matrix effects over the 
concentration range were evident for each antibiotic with differences observed in both LODs 
and IC50s in calibration curves prepared in honey matrix (fortified at the end) compared to 
PBS buffer. Generally, the LODs were higher in fortified honey matrix curves though for 
AMOZ, AOZ and CAP still achieving the target MRPLs. An indication of the recovery of 
each assay can be observed on comparison of the difference between the calibration curves 
fortified before and after extraction. Based on the extraction method applied full recovery of 
the targets when fortified at the beginning of the extraction may not have been achieved 
based on the assumptions to attain 100% recovery. If the curves are overlaying there is 
excellent recovery in the assay but if they vary substantially then there are issues in recovery 
of the extraction method being applied. As can be observed from Figure 4 for each of the 
targets there are marginal differences in the overlay of the calibration curves highlighting 
minimal losses in recovery from the extraction method applied. When blank honey extract 
was fortified at the end of the extraction the IC50 improved for the AMOZ target to 1.4 ng/mL 
compared to 3.0 ng/mL in honey fortified at the beginning of the extraction. For other targets 
the sensitivity was marginally improved to that previously determined in honey fortified at 
the start of the extraction. For SEM the IC50 was 166.6 ng/mL in PBS buffer decreasing to 
272.7 ng/mL in honey (fortified at the start) and 138 ng/mL (fortified at the end). For AHD 
the IC50 was quite high in PBS buffer at 553.8 ng/mL increasing to > 1000 ng/mL in honey 
matrix. Neither SEM nor AHD show the required sensitivity that would meet regulatory 
limits to be used successfully in a testing laboratory.  Based on the comparison of the 
calibration curves determined it may be possible to apply a PBS buffer calibration curve to 
determine the concentration of each target in real samples as opposed to having a supply 
available of known blank honey for all targets to prepare extracted curves. The suitability of 
buffer curves for calibrations would need to be determined in a full validation study. The 
incorporation of a calibration curve for each target allows for the semi-quantitative analysis 
for the target nitrofuran metabolites and CAP as opposed to a qualitative yes / no response 
reflective of the LOD and associated MRPL. 
 
Conclusions 
The feasibility of a novel multispot nanoarray for the semi-quantitative and simultaneous 
screening of AMOZ, AOZ, CAP, SEM and AHD in honey has been illustrated whereby these 
antibiotics were successfully multiplexed into one assay. It was realised that antibodies for 
SEM and AHD were not as sensitive as for the other antibiotics and further improvements to 
the sensitivity to make this multiplex nanoarray more applicable for regulatory testing would 
be necessary. Similarly, with the considerations of the natural occurrence of SEM it may be 
appropriate for rapid methods to source an antibody that differentiates between protein bound 
SEM compared to free SEM as protein bound is believed to be more indicative of 
nitrofurazone usage compared to natural occurrence. The identification of an alternative 
marker would also be important.  
This study has demonstrated the proof of concept of a multiplex nanoarray for multiple 
nitrofuran and chloramphenicol detection with results available for 40 samples within 90 min 
after extraction. The benefit of this assay system is that it follows established ELISA 
protocols, whereby laboratories with immunological screening methods already in place have 
end users familiar with the steps of the analysis. The simplicity and sensitivity of the 
antibiotic nanoarray means it could be used as a multiple target screening technique for many 
antibiotics within the area of residue determination and food safety. This study has shown 
some very promising data that is worthy of further research to determine if this approach is 
suitable for a commercial diagnostic test in the food industry. As the multiplex reader 
technology is relatively new, uptake and implementation would require replacement of 
existing ELISA plate readers. In the food safety diagnostics sector this investment should be 
comparable to existing readers to have potential interest for future users, though 
consideration should also be given to the simultaneous high throughput detection of five 
targets on an established ELISA platform compared to five individual assays which has the 
potential to minimise labour time improving throughput reducing the overall cost of analysis 
in the long term. As traditional antibody based screening methods are now competing in a 
number of laboratories with LC-MS/MS methods as the new screening tools the cost of kits 
for multiplex analysis should be relatively low to be competitive with these LC-MS/MS 
methods. Improvements to the sensitivity for SEM and AHD, the addition of other antibiotics 
to the nanoarray and the detection in different food matrices are also all worthy of further 
evaluations. Additionally, prior to implementation a full validation and inter-laboratory trial 
of the nanoarray should be conducted following accreditation guidelines. To meet with the 
criteria of the EU this would be according to the guidelines for the validation of screening 
methods as outlined in the European decision EC/2002/657. For the collaborative trial the 
availability of multiplex readers would also need consideration. 
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 Figures 
 
 
 
Figure 1: Individual calibration curves for AMOZ, AOZ and CAP in PBS buffer using individual spotted 
microtitre plates at 1 and 5 nL spotting volume (n=2 analysis, 9 spots per analysis). 
 Figure 2: Individual calibration curves for the independent detection of AMOZ, AOZ, CAP, SEM and AHD in 
PBS buffer using a multiplex spotted microtitre plate (n=2 analysis, 5 spots per analysis). 
 
 
 
 
 
Figure 3: Multiplex calibration curves based on the simultaneous detection of AMOZ, AOZ, CAP, SEM and 
AHD in PBS buffer using a multiplex spotted microtitre plate (n=2 analysis, 5 spots per analysis). 
 
 
 
 
      
 
     
 
 
 
Figure 4: Matrix and recovery effects for AMOZ, AOZ, CAP, SEM and AHD in PBS buffer, honey fortified at 
the start of the extraction and blank honey extracts fortified after extraction using multiplex spotted microtitre 
plates (n=2 analysis, 5 spots per analysis).  
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